Literature DB >> 2341178

Effects of cations and osmotic protectants on cytolytic activity of Actinobacillus actinomycetemcomitans leukotoxin.

M Iwase1, E T Lally, P Berthold, H M Korchak, N S Taichman.   

Abstract

Actinobacillus actinomycetemcomitans leukotoxin permeabilized the plasma membrane of HL-60 promyelocytic leukemia cells, resulting in colloid osmotic lysis. These events were associated with efflux of 51chromium (from prelabeled cells), influx of propidium iodide, and ultrastructural evidence of cellular damage. Target cell lysis was inhibited by procedures which may interfere with the initial interaction of the toxin with the plasma membrane. For example, washing cultures (to dilute and remove toxin) or the addition of monoclonal antibodies (to neutralize toxin) or trypsin (to inactivate toxin) limited lysis when undertaken within the first 5 min of the reaction. The extent of injury was also diminished when radiolabeled HL-60 cells were exposed to toxin in the presence of unlabeled, toxin-sensitive cells (e.g., HL-60 cells or human neutrophils) or certain toxin-resistant target cells (e.g., human K562 erythroleukemia cells). This suggests that the association of the toxin with the cell membrane may not be sufficient to cause lysis without activation of additional effector mechanisms. The addition of specific trivalent (e.g., La3+) or divalent (e.g., Ca2+ and Zn2+) cations to toxin-treated cells appeared to enhance their capacity to repair or minimize the extent of toxin-mediated membrane damage. Depending on size, certain saccharides served as osmotic protectants: maltose almost completely inhibited radiolabel release, while smaller molecules provided correspondingly less protection. The results imply that the leukotoxin has membranolytic activity, producing pores in target cells with a functional diameter approximately the size of maltose (0.96 nm).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2341178      PMCID: PMC258723          DOI: 10.1128/iai.58.6.1782-1788.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Membrane damage by hemolytic viruses, toxins, complement, and other cytotoxic agents. A common mechanism blocked by divalent cations.

Authors:  C L Bashford; G M Alder; G Menestrina; K J Micklem; J J Murphy; C A Pasternak
Journal:  J Biol Chem       Date:  1986-07-15       Impact factor: 5.157

3.  Monoclonal antibodies to leukotoxin of Actinobacillus actinomycetemcomitans.

Authors:  J M DiRienzo; C C Tsai; B J Shenker; N S Taichman; E T Lally
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

4.  Nucleotide sequence of the leukotoxin genes of Pasteurella haemolytica A1.

Authors:  R Y Lo; C A Strathdee; P E Shewen
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

5.  Escherichia coli hemolysin is released extracellularly without cleavage of a signal peptide.

Authors:  T Felmlee; S Pellett; E Y Lee; R A Welch
Journal:  J Bacteriol       Date:  1985-07       Impact factor: 3.490

6.  Cloning and expression of the leukotoxin gene from Actinobacillus actinomycetemcomitans.

Authors:  D Kolodrubetz; T Dailey; J Ebersole; E Kraig
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

7.  Escherichia coli hemolysin may damage target cell membranes by generating transmembrane pores.

Authors:  S Bhakdi; N Mackman; J M Nicaud; I B Holland
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

8.  Biochemical and morphological characterization of the killing of human monocytes by a leukotoxin derived from Actinobacillus actinomycetemcomitans.

Authors:  N S Taichman; R T Dean; C J Sanderson
Journal:  Infect Immun       Date:  1980-04       Impact factor: 3.441

9.  Molecular sieving by the Bacillus megaterium cell wall and protoplast.

Authors:  R Scherrer; P Gerhardt
Journal:  J Bacteriol       Date:  1971-09       Impact factor: 3.490

10.  Extraction and isolation of a leukotoxin from Actinobacillus actinomycetemcomitans with polymyxin B.

Authors:  C C Tsai; B J Shenker; J M DiRienzo; D Malamud; N S Taichman
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

View more
  22 in total

1.  Positive and negative cis-acting regulatory sequences control expression of leukotoxin in Actinobacillus actinomycetemcomitans 652.

Authors:  Christine Mitchell; Ling Gao; Donald R Demuth
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

2.  Aggregatibacter actinomycetemcomitans leukotoxin cytotoxicity occurs through bilayer destabilization.

Authors:  Angela C Brown; Kathleen Boesze-Battaglia; Yurong Du; Frank P Stefano; Irene R Kieba; Raquel F Epand; Lazaros Kakalis; Philip L Yeagle; Richard M Epand; Edward T Lally
Journal:  Cell Microbiol       Date:  2012-03-28       Impact factor: 3.715

3.  Bacterial RTX toxins allow acute ATP release from human erythrocytes directly through the toxin pore.

Authors:  Marianne Skals; Randi G Bjaelde; Jesper Reinholdt; Knud Poulsen; Brian S Vad; Daniel E Otzen; Jens Leipziger; Helle A Praetorius
Journal:  J Biol Chem       Date:  2014-05-23       Impact factor: 5.157

4.  Cytocidal and apoptotic effects of the ClyA protein from Escherichia coli on primary and cultured monocytes and macrophages.

Authors:  X H Lai; I Arencibia; A Johansson; S N Wai; J Oscarsson; S Kalfas; K G Sundqvist; Y Mizunoe; A Sjöstedt; B E Uhlin
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

Review 5.  Aggregatibacter actinomycetemcomitans leukotoxin: From mechanism to targeted anti-toxin therapeutics.

Authors:  Eric Krueger; Angela C Brown
Journal:  Mol Oral Microbiol       Date:  2020-03-10       Impact factor: 3.563

6.  Inhibition of P2X Receptors Protects Human Monocytes against Damage by Leukotoxin from Aggregatibacter actinomycetemcomitans and α-Hemolysin from Escherichia coli.

Authors:  Steen K Fagerberg; Martin R Jakobsen; Marianne Skals; Helle A Praetorius
Journal:  Infect Immun       Date:  2016-10-17       Impact factor: 3.441

7.  Regulation of Actinobacillus actinomycetemcomitans leukotoxin expression: analysis of the promoter regions of leukotoxic and minimally leukotoxic strains.

Authors:  J M Brogan; E T Lally; K Poulsen; M Kilian; D R Demuth
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

8.  Association of Actinobacillus actinomycetemcomitans leukotoxin with nucleic acids on the bacterial cell surface.

Authors:  H Ohta; H Hara; K Fukui; H Kurihara; Y Murayama; K Kato
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

9.  Mechanism of action of Moraxella bovis hemolysin.

Authors:  K D Clinkenbeard; A E Thiessen
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

10.  Cloning and characterization of the Actinobacillus pleuropneumoniae-RTX-toxin III (ApxIII) gene.

Authors:  R Jansen; J Briaire; E M Kamp; A L Gielkens; M A Smits
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.